Pharmaceutical
April 7, 2011
Bloomberg reports that Merck & Co. has failed to win U.S. approval to expand use of the cervical-cancer vaccine Gardasil to older women. The FDA didn’t grant the company’s application
Read More
April 6, 2011
According to PRNewswire, Shire LLC has filed a lawsuit in the U.S. District Court for the Southern District of New York against Watson Pharmaceuticals, Inc. and its subsidiaries Watson Laboratories,
Read More
March 31, 2011
Abbott Laboratories must pay GlaxoSmithKline $3.5 million in damages for breaching an agreement over an AIDS drug, reports Bloomberg. The jury cleared the company of claims that it sought
Read More
March 29, 2011
To help consumers better understand the true value, reliability and high quality of generics, Mylan Inc. has launched an educational website about generics drugs, www.ChoosingGenerics.com, reports PRNewswire. ChoosingGenerics.com calls on
Read More
March 24, 2011
Bloomberg reports that Pfizer Inc.’s former chairman and CEO William Steere is retiring from the board after building the world’s biggest drugmaker with acquisitions and products led by the Lipitor
Read More
March 22, 2011
The Associated Press reports that shares of Bristol-Myers Squibb Co. rose Tuesday morning following an announcement that the company''s highly anticipated melanoma drug improved survival times when used as a
Read More
March 21, 2011
According to Business Wire, Bull & Lifshitz, LLP recently announced an investigation into possible breaches of fiduciary duty in connection with the proposed acquisition of The Lubrizol Corporation by
Read More
March 21, 2011
Swiss drug maker Novartis AG says it has received European Union approval to sell its oral multiple sclerosis medication Gilenya in the 27-nation bloc, according to the Associated Press. The
Read More
March 17, 2011
According to the Associated Press, health care giant Johnson & Johnson lowered Chief Executive William Weldon''s total compensation by 9 percent in 2010, after two years of revenue declines and
Read More
March 16, 2011
According to the Associated Press, Eli Lilly and Co. plans to buy the animal health business of Janssen Pharmaceutical NV in a deal that would give Lilly''s Elanco division about
Read More